Referral and adjuvant treatment patterns after nephrectomy in high-risk locoregional renal cell carcinoma.

ABSTRACT:

Background

It is unclear whether patients with renal cell carcinoma (RCC) are routinely assessed for recurrence risk post-nephrectomy and whether patients at high recurrence risk are seen by providers who can evaluate candidacy for adjuvant systemic therapy (AST) and clinical trials.

Materials and methods

We identified all patients with locoregional RCC who underwent nephrectomy via an institutional database within Duke University Health System between 1 April 2015 and 31 December 2019. Medical records were reviewed to identify patient characteristics, post-nephrectomy referrals, treatment, and follow-up. Patients with tumor stage ≥3 and grade ≥2, regional lymph node metastasis, or both, were classified as high recurrence risk.

Results

Of 618 patients with locoregiona

SUBMITTER: Dzimitrowicz H 

PROVIDER: S-EPMC8683553 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature